Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.

Ng TKS, Ho CSH, Tam WWS, Kua EH, Ho RC. · 2019

Read Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis. by Ng TKS, Ho CSH, Tam WWS, Kua EH, Ho RC. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6358753.txt.

Description

Ng and co-authors present a systematic review and meta-analysis in the International Journal of Molecular Sciences. Their subject is BDNF, a protein that helps brain cells grow and survive. Past studies disagreed on whether blood levels of BDNF fall in Alzheimer's disease.

Pooling fifteen studies with 2,067 people, they found lower serum BDNF in patients than in healthy controls. Levels in mild cognitive impairment were less clear. Age and test scores for memory helped explain why study results differed. The authors treat low BDNF as a possible sign of the disease. They note that varied methods still limit firm claims.

Catalog record

CREATORNg TKS, Ho CSH, Tam WWS, Kua EH, Ho RC.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6358753

Browse the full library · About the Tower of Babel